{"name":"ENCUBE","slug":"encube","ticker":"","exchange":"","domain":"encube.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Elimite™ Cream (permethrin) 5%","genericName":"Elimite™ Cream (permethrin) 5%","slug":"elimite-cream-permethrin-5","indication":"Scabies (Sarcoptes scabiei infestation)","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Solaraze 3% Topical Gel","genericName":"Solaraze 3% Topical Gel","slug":"solaraze-3-topical-gel","indication":"Moderate to severe plaque psoriasis","status":"phase_3"}]}],"pipeline":[{"name":"Elimite™ Cream (permethrin) 5%","genericName":"Elimite™ Cream (permethrin) 5%","slug":"elimite-cream-permethrin-5","phase":"phase_3","mechanism":"Permethrin is a synthetic pyrethroid insecticide that disrupts sodium channel function in the nervous system of parasites, causing paralysis and death.","indications":["Scabies (Sarcoptes scabiei infestation)","Head lice (Pediculus humanus capitis infestation)"],"catalyst":""},{"name":"Solaraze 3% Topical Gel","genericName":"Solaraze 3% Topical Gel","slug":"solaraze-3-topical-gel","phase":"phase_3","mechanism":"Solaraze 3% Topical Gel is a topical gel formulation of tazarotene, a retinoid that modulates the expression of genes involved in cell proliferation and differentiation.","indications":["Moderate to severe plaque psoriasis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}